Abstract
The cameral mucous gel (CMG) has been described as a layer of glycoprotein-enriched hyaluronic acid lining the anterior surface of the iris, covering the trabecular meshwork, and spreading over the posterior surface of the cornea. The CMG is thought to exert a colloid-osmotic effect on the hydrostatic forces involved in the circulation of the aqueous humour which may help our understanding of the pathophysiology of open angle and angle closure glaucomas. The CMG was precipitated in two normal human eyes, one with an artificially shortened anterior chamber and the other with an open chamber. In the eye with a narrow angle, the CMG was seen to fill the iridocorneal gap completely, blocking access to the trabecular meshwork from the central anterior chamber. The CMG may be implicated in the pathogeny of narrow angle and closed angle glaucoma. The two types of glaucoma may share a common mechanism depending on the thickness of the layer of CMG that precedes the exit pathways. Pretrabecular CMG thickness is a decisive determinant of the colloid-osmotic resistance of the gel to aqueous outflow, and this thickness is governed by, among other factors, the position of the iris relative to the posterior surface of the cornea. The formation of a thick layer of CMG in the narrow chamber angle prevents the normal anterior chamber pressure from exerting a backward displacement effect on the peripheral iris. Unopposed posterior chamber pressure may therefore force the peripheral iris forward, making angle closure likely.
Similar content being viewed by others
Article PDF
References
Curran EJ . A new operation for glaucoma involving a new principle in the aetiology and treatment of chronic primary glaucoma. Arch Ophthalmol 1920;49:131–40.
Barkan O . Glaucoma: classification, causes and surgical control. Results of microgonioscopic research. Am J Ophthalmol 1938;21:1099–117.
Mapstone R . Pathological physiology of primary closed angle glaucoma. In: Cairns JE. editor. Glaucoma, vol. I. London: Grune and Stratton, 1986:311–27.
Lowe RF . Primary creeping angle-closure glaucoma. Br J Ophthalmol 1964;48:544–7.
Chandler PA, Trotter RR . Angle-closure glaucoma: subacute types. Arch Ophthalmol 1955;53:305–17.
Lowe RF . The natural history and principles of treatment of primary angle closure glaucoma. Am J Ophthalmol 1966;61:642–51.
Wishart PK . Can the pilocarpine phenylephrine provocative test be used to detect covert angle closure? Br J Ophthalmol 1991;75:615–8.
Wishart PK . Does the pilocarpine phenylephrine provocative test help in the management of acute and subacute angle closure glaucoma? Br J Ophthalmol 1991;75:284–7.
Bàràny EH, Scotchbrook S . Influence of testicular hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Physiol Scand 1954;30:240–8.
Zimmerman LE . Demonstration of hyaluronidase sensitive acid mucopolysaccharides in trabecula and iris in routine paraffin sections of adult human eyes. Am J Ophthalmol 1957;44:l–4.
Duke JR, Siegelman S . Acid mucopolysaccharides in the trabecular meshwork of the chamber angle. Arch Ophthalmol 1961;66:399–404.
Rohen JW, Witmer R . Electron microscopic studies on the trabecular meshwork in glaucoma simplex. Graefes Arch Clin Exp Ophthalmol 1972;183:251–66.
Lutjen-Drecoll E, Shimizu T, Rohrbach M, Rohen JW . Quantitative analysis of ‘plaque material’ in the inner and outer wall of Schlemm's canal in normal and glaucomatous eye. Exp Eye Res 1986;42:443–55.
Buller C, Johnson D . Segmental variability of the trabecular meshwork in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 1994;35:3841–5.
Segawa K . Localisation of acid mucopolysaccharides in the human trabecular meshwork. Jpn J Clin Ophthalmol 1970;24:363–7.
Grierson I, Lee WR, Abrahams S . The appearance of the outflow apparatus of the eye after staining with ruthenium red. Acta Ophthalmol (Copenh) 1977;55:827.
Gong H, Underhill CB, Freddo TF . Hyaluronan in the bovine ocular anterior segment, with emphasis in the anterior pathways. Invest Ophthalmol Vis Sci 1994;35:4328–32.
Lütjen-Drecoll E, Schenholm M, Tamm E, Tengblad A . Visualization of hyaluronic acid in the anterior segment of rabbit and monkey eyes. Exp Eye Res 1990;51:55–63.
Tamm ER, Lütjen-Drecoll E . Advances in morphologic glaucoma research. Curr Opin Ophthalmol 1992;3:141–8.
Johnson M, Gong H, Freddo TF, Ritter N, Kamm R . Serum proteins and aqueous outflow resistance in bovine eyes. Invest Ophthalmol Vis Sci 1993;34:3549–57.
Freddo TF, Bartels SP, Barsotti MF, Kamm RD . The source of proteins in the aqueous humor of the normal rabbit. Invest Ophthalmol Vis Sci 1990;31:125–37.
Barsotti MF, Bartels SP, Freddo TF, Kamm RD . The source of protein in the aqueous humor of the normal monkey eye. Invest Ophthalmol Vis Sci 1992;33:581–95.
Carreras FJ, Lopez-Caballero J, Porcel D . A gel of glycosaminoglycans lining anterior and posterior chambers in man: histochemical evidence at light and electron microscopy level. Eye 1992;6:574–82.
Carreras FJ, Porcel D, Lopez-Caballero JJ . Characterization of proteoglycans in the human cameral mucous gel by lectins. Ophthalmic Res 1994;26:275–82.
Carreras FJ, Porcel D . Chondroitin sulfate is a major proteoglycan constituent of human cameral mucous gel. Ophthalmic Res 1995;27:53–6.
Ethier CR, Kamm RD, Palaszewsky BA, Richardson TM . Calculations of flow resistance in the juxtacanalicular meshwork. Invest Ophthalmol Vis Sci 1986;127:1741–50.
Bhargava SK, Leighton DA, Philips CI . Early angle-closure glaucoma: distribution of iridotrabecular contact and response to pilocarpine. Arch Ophthalmol 1973;89:369–72.
Mapstone R . Mechanisms in ocular hypertension. Br J Ophthalmol 1979;63:325–30.
Høvding G, Aasved H . Angle closure glaucoma. Curr Opin Ophthalmol 1992;3:149–53.
Greenidge KC . Angle-closure glaucoma: a review of mechanisms. Curr Opin Ophthalmol 1991;2:133–9.
Inoue T, Yamamoto T, Kitazawa Y . Distribution and morphology of peripheral anterior synechiae in primary angle-closure glaucoma. J Glaucoma 1993;2:1716.
Abramson DH, Chang S, Coleman J . Pilocarpine therapy in glaucoma: effects in anterior chamber depth and lens thickness in patients receiving long-term therapy. Arch Ophthalmol 1976;94:914–8.
Lütjen-Drecoll E . Kaufman PL. Morphological change in primate aqueous humour formation and drainage tissues after long-term treatment with antiglaucomatous drugs. J Glaucoma 1993;2:316–28.
Lowe RF . Causes of shallow anterior chamber in primary angle closure glaucoma: ultrasonic biometry of normal and angle-closure glaucoma eyes. Am J Ophthalmol 1969;67:87–93.
Salmon JF, Swanevelder SA, Donald MA . The dimensions of eyes with chronic angle-closure glaucoma. J Glaucoma 1994;3:237–43.
Jackson RL, Busch SJ, Cardin AD . Glycosaminoglycans: molecular properties, protein interactions and role in physiological processes. Physiol Rev 1991;71:481–539.
Epstein DL, Hashimoto JM, Grant WM . Serum obstruction of aqueous outflow in enucleated eyes. Am J Ophthalmol 1978;86:101–5.
Ogston AG . The biological functions of the glycosaminoglycans. In: Balazs EA, editor. Chemistry and molecular biology of the intercellular matrix, vol. 3. New York: Academic Press, 1970:1231–40.
Preston BN, Davies M, Ogston AG . The composition and physicochemical properties of hyaluronic acids prepared from ox synovial fluid and from a case of mesothelioma. Biochem J 1965;96:449–71.
Greenidge KC . Angle closure glaucoma: a review of mechanisms. Curr Opin Ophthalmol 1991;2:133–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carreras, F., González-Caballero, F. Role of cameral mucous gel in primary narrow angle and closed angle glaucoma: A pathogenic clue. Eye 9, 619–623 (1995). https://doi.org/10.1038/eye.1995.150
Issue Date:
DOI: https://doi.org/10.1038/eye.1995.150